ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.740
+0.110 (6.75%)
At close: Jan 17, 2025, 4:00 PM
1.750
+0.010 (0.57%)
After-hours: Jan 17, 2025, 6:47 PM EST
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $91.77 million as of January 17, 2025. Its market cap has decreased by -87.19% in one year.
Market Cap
91.77M
Enterprise Value
-39.44M
1-Year Change
-87.19%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $91.77M, a decrease of -91.31%. That is a compound annual growth rate of -41.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 91.77M | 4.19% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |